Page 7 - Cipla

Stocks to Watch: Mazagon Dock, Tata Motors, REC, Blue Dart, Cipla, Lloyd

Stocks to Watch on December 11, 2023: REC has signed a 200-million-euro loan agreement with the German bank KfW to enhance the distribution infrastructure of discoms

Warning Letter for Pithampur SEZ facility remains an overhang for Cipla

While some brokerages believe that the issue could escalate and be detrimental for Cipla, others believe that the Warning Letter was on expected lines and the impact may not be meaningful

Cipla's Pithampur unit gets USFDA warning; analysts remain bullish

On Monday, Cipla share price dropped 0.21 per cent, ending the day's trade at Rs 1,246 apiece on the BSE

Stocks to Watch: L&T, Bharti Airtel, SBI Card, Dixon, Cipla, Bajaj Finance

Stocks to watch on November 20, 2023: SBI Card said that its capital adequacy ratio is expected to decline by 4 per cent due to the RBI's latest move on tightening consumer loan norms

Cipla concludes 51.18% stake sale in Ugandan subsidiary for $25 million

The sale was executed by Cipla (EU) Limited, UK, and Meditab Holdings Limited, Mauritius, both wholly-owned subsidiaries of Cipla Limited

Cipla announces transfer of Generics Business Undertaking to subsidiary

The generics business contributed 9.95 per cent of Cipla's turnover and 0.92 per cent of its net worth in the financial year ended March 31, 2023

US sales momentum, margin gains to support pharma major Cipla's stock

Led by the US market which rose by 31 per cent, the company posted a 16 per cent growth in revenues

US sales momentum, upward revision in margin guidance to support Cipla

The company's market share in Lanreotide (growth hormone disorder drug) improved from 18 per cent in Q1FY24 to 20 per cent now

Cipla surges 4% on beating Q2 estimates; profit jumps 43%, revenue up 15%

The positive growth was aided by strength in domestic as well as US sales. Its overall Q2 revenue was its highest ever in a quarter, Cipla said.

Markets snap 6-day losing run; Sensex jumps 635 pts, Nifty nears 19,050

Closing Bell on October 27, 2023: Among sectors, the Nifty PSU Bank index jumped 4 per cent today

Cipla profit rises 45% to Rs 1,156 cr, sales up 14.4% to Rs 6,590 cr in Q2

Consolidated total revenue from the sale of products in the quarter under review stood at Rs 6,589.22 crore, up 14.41 per cent, as against Rs 5,759.28 crore in the year-ago period

Cipla Q2 net profit seen rising 25% YoY; US sales may drop QoQ to $215 mn

Cipla Q2FY24 result preview: On a sequential basis (QoQ), Cipla's net profit is seen declining 1.1 per cent, while revenue may grow 2.2 per cent

Torrent lines up at least $5 billion funding to buy 33% stake in Cipla

Torrent has secured commitments from a group of overseas banks for a potential deal, the people said, asking not to be identified as the information is not public

Biocon Biologics appoints Kedar Upadhye as new chief financial officer

Current CFO, MB Chinappa will take on a strategic finance role at Biocon Group

Sensex down 316pts, Nifty below 19550 amid global selling; JSW Infra up 32%

Closing Bell on October 3, 2023: In the broader markets, the key indices outperformed the frontline indices with the BSE MidCap index gaining 0.09%, and the BSE SmallCap index advancing 0.6%

Cipla to deliver essential medicines through drones in Himachal Pradesh

Company aims to scale drone operations in Uttarakhand and NE India

Stocks to Watch today, Sep 27: Infy, HealthCare Global, Suzlon, Century Tex

Stocks to watch on Wednesday, September 27, 2023: Shares of SignatureGlobal (India) and Sai Silk (Kalamandir) to debut on the bourses today.

Cipla introduces drone-powered critical medicine delivery in Himachal

Drug major Cipla on Tuesday said it has introduced drone-powered deliveries of critical medicines for hospitals and pharmacies in Himachal Pradesh in partnership with Sky Air Mobility. The Mumbai-based firm aims to deliver medicines for cardiac, respiratory and other essential chronic therapies as part of the initiative. The use of drones will support on-time deliveries of the company's medicines to chemists and clinics in remote areas while minimising risks such as delays, temperature excursions affecting cold chain products, and roadside accidents, Cipla said in a statement. "As we accelerate our digital agenda across all functions, implementing drone-powered distribution enhances our supply chain resilience, strengthens connects with channel partners, helps us stay future ready and maintain reliable, prompt delivery of our trusted high-quality drugs to stockists and patients in the region," Cipla Global Supply Chain Head Swapn Malpani said. The drug firm said it also aims to sca

Cipla's US subsidiary InvaGen gets 5 inspectional observations from USFDA

The inspection was a routine current Good Manufacturing Practices (cGMP) inspection and a Pre-Approval Inspection (PAI) for a site transfer product within InvaGen

Stocks to Watch on Sept 21: Infosys, Sheela Foam, SJVN, Cipla, DCB Bank

Stocks to Watch today, September 21, 2023: The government will sell up to 4.9 per cent stake in SJVN via offer for sale (OFS) on Thursday and Friday